Alphatec Holdings (ATEC)

• Market cap: $1.33B
• 1 day: 5.65%
• 5 days: -2.60%
• 1 month: -5.84%
• 3 months: 55.06%
• 6 months: -8.78%
• Year to date: -37.04%
• 1 year: -35.52%
• 5 years: 33.19%
• 10 years: -43.54%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Employees: 839

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

48% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 58

1% less funds holding

Funds holding: 216 [Q2] → 214 (-2) [Q3]

4% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 45

8.36% less ownership

Funds ownership: 67.42% [Q2] → 59.06% (-8.36%) [Q3]

53% less capital invested

Capital invested by funds: $986M [Q2] → $461M (-$524M) [Q3]

54% less call options, than puts

Call options by funds: $2.25M | Put options by funds: $4.92M

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $13 39% upside
• Avg. target: $17.67 89% upside
• High target: $20 114% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Barclays Matt Miksic 61% 1-year accuracy 22 / 36 met price target	114% upside $20	Overweight Maintained	19 Nov 2024
Needham David Saxon 25% 1-year accuracy 15 / 61 met price target	39% upside $13	Buy Reiterated	31 Oct 2024
HC Wainwright & Co. Sean Lee 60% 1-year accuracy 12 / 20 met price target	114% upside $20	Buy Reiterated	31 Oct 2024